These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight. Nalluri N; Patel N; Saouma S; Anugu VR; Anugula D; Asti D; Mehta V; Kumar V; Atti V; Edla S; Grewal RK; Khan HM; Kanotra R; Maniatis G; Kandov R; Lafferty JC; Dyal M; Alfonso CE; Cohen MG Expert Rev Med Devices; 2017 Oct; 14(10):789-804. PubMed ID: 28862481 [TBL] [Abstract][Full Text] [Related]
68. Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy. Pahuja M; Hernandez-Montfort J; Whitehead EH; Kawabori M; Kapur NK Expert Rev Med Devices; 2022 Jan; 19(1):1-10. PubMed ID: 34894975 [TBL] [Abstract][Full Text] [Related]
69. Left ventricular outflow tract obstruction following an uncomplicated primary percutaneous coronary intervention: a recognized but rare cause of cardiogenic shock. Khan S; Ripley D; de Belder M; Goodwin A; Barham N; Wright R Eur Heart J Acute Cardiovasc Care; 2013 Mar; 2(1):68-71. PubMed ID: 24062935 [TBL] [Abstract][Full Text] [Related]
70. Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre. Monteagudo Vela M; Simon A; Riesgo Gil F; Rosenberg A; Dalby M; Kabir T; García Saez D; Panoulas V Cardiovasc Revasc Med; 2020 May; 21(5):629-637. PubMed ID: 31859100 [TBL] [Abstract][Full Text] [Related]
71. Cardiac arrest complicating cardiogenic shock: from pathophysiological insights to Impella-assisted cardiopulmonary resuscitation in a pheochromocytoma-induced Takotsubo cardiomyopathy-a case report. Zilio F; Muraglia S; Bonmassari R Eur Heart J Case Rep; 2021 Mar; 5(3):ytab092. PubMed ID: 34113770 [TBL] [Abstract][Full Text] [Related]
72. Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle. Josiassen J; Helgestad OKL; Udesen NLJ; Banke A; Frederiksen PH; Hyldebrandt JA; Schmidt H; Jensen LO; Hassager C; Ravn HB; Møller JE Intensive Care Med Exp; 2020 Aug; 8(1):41. PubMed ID: 32785808 [TBL] [Abstract][Full Text] [Related]
73. Impella-Induced Incessant Ventricular Tachycardia. Kaki A; Subahi A; Shokr M; Ibrahim W; Yassin A; Hasan R; Alraies MC; Schreiber T Ochsner J; 2019; 19(3):248-251. PubMed ID: 31528136 [No Abstract] [Full Text] [Related]
74. Takotsubo cardiomyopathy complicated with acute pericarditis and cardiogenic shock. Guevara R; Aguinaga-Meza M; Hazin MI; Hazin R; McCord J J Natl Med Assoc; 2007 Mar; 99(3):281-3. PubMed ID: 17393953 [TBL] [Abstract][Full Text] [Related]
75. A handicap in Takotsubo cardiomyopathy: dynamic outflow obstruction. Keskin M; Tanık VO; Gümüşdağ A; Yıldırımtürk Ö Turk Kardiyol Dern Ars; 2016 Mar; 44(2):161-5. PubMed ID: 27111317 [TBL] [Abstract][Full Text] [Related]
76. Long-Term Clinical Outcome of Cardiogenic Shock Patients Undergoing Impella CP Treatment vs. Standard of Care. Scherer C; Lüsebrink E; Kupka D; Stocker TJ; Stark K; Stremmel C; Orban M; Petzold T; Germayer A; Mauthe K; Kääb S; Mehilli J; Braun D; Theiss H; Brunner S; Hausleiter J; Massberg S; Orban M J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33255393 [TBL] [Abstract][Full Text] [Related]
77. Vasopressin in Patients with Septic Shock and Dynamic Left Ventricular Outflow Tract Obstruction. Balik M; Novotny A; Suk D; Matousek V; Maly M; Brozek T; Tavazzi G Cardiovasc Drugs Ther; 2020 Oct; 34(5):685-688. PubMed ID: 32488425 [TBL] [Abstract][Full Text] [Related]
78. High-risk catheter ablation of refractory atrial fibrillation using Impella CP in a patient with cardiogenic shock. Osei K; Taskesen T; Hounshell T; Meyers J Pacing Clin Electrophysiol; 2020 Oct; 43(10):1205-1209. PubMed ID: 32790098 [TBL] [Abstract][Full Text] [Related]
79. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry. Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180 [TBL] [Abstract][Full Text] [Related]
80. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center. Vecchio S; Chechi T; Giuliani G; Lilli A; Consoli L; Spaziani G; Giannotti F; Margheri M Minerva Cardioangiol; 2008 Aug; 56(4):391-9. PubMed ID: 18614983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]